Journal of the Neurological Sciences
Volume 287, Issue 1 , Pages 45-51 , 15 December 2009

Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: Results from 1-year outcomes in the Japanese REACH Registry

  • Shinichiro Uchiyama

      Affiliations

    • Department of Neurology, Tokyo Women's Medical University School of Medicine, Tokyo, Japan
    • Corresponding Author InformationCorresponding author. Department of Neurology, Tokyo Women's Medical University School of Medicine, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan. Tel.: +81 3 3353 8111; fax: +81 3 3341 0613.
    • ,
  • Shinya Goto

      Affiliations

    • Department of Medicine, Tokai University School of Medicine, Kanagawa, Japan
    • ,
  • Masayasu Matsumoto

      Affiliations

    • Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan
    • ,
  • Ryozo Nagai

      Affiliations

    • Department of Cardiology, University of Tokyo, Tokyo, Japan
    • ,
  • Hideki Origasa

      Affiliations

    • Division of Biostatistics and Clinical Epidemiology, University of Toyama, Toyama, Japan
    • ,
  • Tsutomu Yamazaki

      Affiliations

    • Department of Pharmacoepidemiology, Graduate School of Medicine, University of Tokyo, Tokyo, Japan
    • ,
  • Hiroshi Shigematsu

      Affiliations

    • Department of Vascular Surgery, Tokyo Medical University, Tokyo, Japan
    • ,
  • Kazuyuki Shimada

      Affiliations

    • Department of Cardiology, Jichi Medical University, Tochigi, Japan
    • ,
  • Nobuhiro Yamada

      Affiliations

    • Department of Metabolism and Endocrinology, University of Tsukuba, Ibaraki, Japan
    • ,
  • Deepak L. Bhatt

      Affiliations

    • VA Boston Healthcare System and Brigham and Women's Hospital, Boston, USA
    • ,
  • P. Gabriel Steg

      Affiliations

    • INSERM U-698, Université Paris 7 and Assistance Publique, Hôpitaux de Paris, Paris, France
    • ,
  • Yasuo Ikeda

      Affiliations

    • Department of Medicine, Keio University School of Medicine, Tokyo, Japan
    • ,
  • on behalf of the REACH Registry Investigators

Received 12 March 2009 ,Revised 13 August 2009 ,Accepted 10 September 2009.

References 

  1. Jemal A, Ward E, Hao Y, Thun M. Trends in the leading causes of death in the United States, 1970–2002. JAMA. 2005;294:1255–1259
  2. Japanese Statistics and Information Department. Abridged life tables for Japan. 2005;accessed on Feb 26, 2007
  3. Yamazaki T, Goto S, Shigematsu H, Shimada K, Uchiyama S, Nagai R, et al. Prevalence, awareness, and treatment of cardiovascular risk factors in patients at high risk of atherothrombosis in Japan. Results from domestic baseline data of the REduction of Atherothrombosis for Continued Health (REACH) registry. Circ J. 2007;71:995–1003
  4. Ohman EM, Bhatt DL, Steg PG, Goto S, Hirsch AT, Liau CS, et al. The REduction of Atherothrombosis for Continued Health (REACH) Registry: an international, prospective, observational investigation in subjects at risk for atherothrombotic events—study design. Am Heart J. 2006;151:786
  5. Chang IM, Gelman R, Pagano M. Corrected group prognostic curves and summary statistics. J Chronic Dis. 1982;35:669–674
  6. Steg PG, Bhatt DL, Wilson PW, D'Agostino RS, Ohman EM, Röther J, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA. 2007;297:1197–1206
  7. Bhatt DL, Steg PG, Ohman EM, Hirsch AT, Ikeda Y, Mas JL, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA. 2006;295:180–189
  8. Goto S, Bhatt DL, Rother J, Alberts M, Hill MD, Ikeda Y, et al. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. Am Heart J. 2008;156:855–863
  9. Liu L, Ikeda K, Yamori Y. Changes in stroke mortality rates for 1950 to 1997: a great slowdown of decline trend in Japan. Stroke. 2001;32:1745–1749
  10. Kobayashi S. Stroke Databank. Tokyo: Nakayama Shoten K.K; 2005;
  11. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996;348:1329–1339
  12. Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Burvill PW, Anderson CS, et al. Five-year survival after first-ever stroke and related prognostic factors in the Perth Community Stroke Study. Stroke. 2000;31:2080–2086
  13. Yamaguchi T. Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation: a multicenter, prospective, randomized trial. Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study Group. Stroke. 2000;31:817–821
  14. Diener HC, Bogousslavsky J, Brass LM, Cimminiello CsibaL, Kaste M, et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attach in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004;364:331–337
  15. Toyoda K, Yasaka M, Iwade K, Nagata K, Koretsune Y, Sakamoto T, et al. Dual antithrombotic therapy increases severe bleeding events in patients with stroke and cardiovascular disease: a prospective multicenter observational study. Stroke. 2008;39:1740–1745
  16. Fukuuchi Y, Tohgi H, Okudera T, Ikeda Y, Miyanaga Y, Uchiyama S, et al. A randomized, double-blind study comparing the safety and efficacy of clopidogrel versus ticlopidine in Japanese patients with noncardioembolic cerebral infarction. Cerebrovasc Dis. 2008;25:40–49
  17. Liao JK. Secondary prevention of stroke and transient ischemic attack: is more platelet inhibition the answer?. Circulation. 2007;115:1615–1621
  18. Plosker GL, Lyseng-Williamson KA. Clopidogrel: a review of its use in the prevention of thrombosis. Drugs. 2007;67:613–646
  19. Bhatt DL, Kapadia SR, Yadav JS, Topol EJ. Update on clinical trials of antiplatelet therapy for cerebrovascular diseases. Cerebrovasc Dis. 2000;10(Suppl. 5):34–40
  20. Missault L, Krygier C, Lukito G, Mary-Rabine L. Occurrence of peripheral arterial disease in a Belgian cohort of patients with cardiovascular history of atherothrombosis. Acta Chir Belg. 2007;107:508–514
  21. Cheng SW, Wu LL, lau H, Ting AC, Wong J. Prevalence of significant carotid stenosis in Chinese patients with peripheral and coronary artery disease. Aust N Z Surg. 1999;69:44–47
  22. Leng GC, Fowkes FG, Lee AJ, Dunbar J, Housley E, Ruckley CV. Use of ankle brachial pressure index to predict cardiovascular events and death: a cohort study. BMJ. 1996;313:1440–1444
  23. Hiatt WR. Preventing atherothrombotic events in peripheral arterial disease: the use of antiplatelet therapy. J Intern Med. 2002;251:193–206
  24. Ferrières J, Cambou JP, Gayet JL, Herrmann MA, Leizorovicz A. Prognosis of patients with atherothrombotic disease: a prospective survey in a non-hospital setting. Int J Cardiol. 2006;112:302–307

PII: S0022-510X(09)00853-3

doi: 10.1016/j.jns.2009.09.011

Journal of the Neurological Sciences
Volume 287, Issue 1 , Pages 45-51 , 15 December 2009

Article Tools